MedTrace Logo

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

NCT07413874 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this clinical trial is to explore if a telehealth music therapy intervention helps with quality of life, depression symptoms, anxiety symptoms. It will also explore the participants' relationship to music. The main questions it aims to answer are:

* Refine and tailor the music therapy intervention to fit the specific needs of adults living with an autoimmune disease and depression.
* Examine the feasibility of the study protocol to support a future full-scale trial
* Examine how music therapy impacts quality of life, depression symptoms, and anxiety symptoms
* Explore how music therapy impacts one's relationship to music

Participants will:

* have a short interview where you'll fill out a questionnaire with some basic information, answers about your depression, quality of life, and potential anxiety, and a question about how you feel about music at the start and end of the sessions
* attend 8 weekly sessions, approximately 30-45 minutes each, with a board certified music therapist over telehealth/Zoom
* answer a few questions about the music therapy intervention

Conditions

  • Type 1 Diabetes
  • Hashimoto Disease
  • Graves Disease
  • Addison Disease
  • Autoimmune Polyglandular Syndrome Type III
  • Depression
  • Endocrine System Diseases

Interventions

BEHAVIORAL

Telehealth Resource Oriented Music Therapy

The interventions used during the sessions may include any of the following: Creating play lists, Song discussion, Song writing, Improvisation/Electronic music creation, Music assisted relaxation, Music listening journal, and Music combined with art creation as a form of receptive music therapy.

Sponsors & Collaborators

  • Meredith Wilson Foundation

    collaborator UNKNOWN

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Appalachian State University

    lead OTHER

Principal Investigators

  • Melody Schwantes, PhD, MT-BC · Appalachian State University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07413874 on ClinicalTrials.gov